SCHEMBL21167774

SCHEMBL21167774

CCn1cc(-c2cnc(N)c(N(N)Cc3csc4ncccc34)n2)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.45
ATR Q13535 1/20 0.42
BTK Q06187 1/20 0.35
MAPK1 P28482 2/20 0.35
PIM1 P11309 5/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
LRRK2 Q5S007 1/20 0.34
PIM3 Q86V86 3/20 0.33
PIM2 Q9P1W9 3/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
SYK P43405 1/20 0.33
FGFR1 P11362 1/20 0.33
FGFR2 P21802 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21167343 0.90 MET (0.44) METJAK2JAK1TYK2JAK3
SCHEMBL22475785 0.89 MET (0.56) METMAPK1MAPTFGFR1FGFR2
SCHEMBL21167541 0.87 MET (0.44) METMAPK1PIM1SYKFGFR1
SCHEMBL21167378 0.79 MET (0.40) METPIM1JAK2JAK1TYK2
SCHEMBL21167577 0.78 MET (0.52) METPIM1MAPTCSF1R
SCHEMBL23127940 0.74 ATR (0.41) METATRMAPK1PIM1LRRK2
SCHEMBL12489807 0.73 MET (0.80) MET
SCHEMBL21167339 0.71 MET (0.43) METJAK2JAK1TYK2JAK3
SCHEMBL24590984 0.70 MET (0.56) METMAPK1FGFR1FGFR2FGFR4
SCHEMBL22109430 0.69 MET (0.45) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-B1 CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LTD (CN) 2022-07-06 EP disclosed
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed